XTalks

MARCH 25, 2024

However, she emphasized, “Our strong marketing plans, innovation and brand investments will drive top-line growth and meet consumers’ evolving needs.” Despite these challenges, companies like Hershey remain optimistic, focusing on marketing, innovation and brand investments to drive growth.

Production 110

Production Manufacturing Branding Marketing 110

Pharmaceutical Technology

AUGUST 1, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.8% in July 2022.

130

130

Pharmaceutical Technology

JULY 27, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.6% in June 2022.

130

130

Pharmaceutical Technology

JULY 18, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 6.1% in June 2022.

130

130

Pharmaceutical Technology

JULY 13, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 11% in June 2022.

130

130

Pharmaceutical Technology

JULY 4, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 6.3% in June 2022.

130

130

Pharmaceutical Technology

JUNE 23, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.6% in May 2022.

130

130

Pharmaceutical Technology

NOVEMBER 8, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in October 2022.

130

130

Pharmaceutical Technology

SEPTEMBER 21, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.6% in August 2022.

130

130

Pharmaceutical Technology

AUGUST 10, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 5.8% in July 2022.

130

130

Pharmaceutical Technology

AUGUST 8, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 3.3% in July 2022.

130

130

Pharmaceutical Technology

AUGUST 3, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in July 2022.

130

130

Pharmaceutical Technology

JULY 20, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 0.9% in June 2022.

130

130

Pharmaceutical Technology

JULY 11, 2022

Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges. The average among all companies stood at 4.7% in June 2022.

130

130

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Without a guaranteed return on investment (ROI), it is understandable why any for-profit company would show reluctance. Efforts have been made to change this. Go-to-market strategies.

Drugs 147

Drugs Medicine Marketing Development 147

Intouch Solutions

JUNE 27, 2023

This means Universal Analytics will stop processing data that’s highly sought-after to inform marketing strategies, inhibiting marketers to substantiate their investments. So, are you ready to migrate to G4A to focus more on user engagement with your brand? Events – Event Name and Detail replaces Event Category, Action, and Label.

Marketing 98

Marketing Branding Development 98

Scienmag

SEPTEMBER 9, 2020

Massive price tag of COVID-19 response in 73 low- and middle-income countries underscores benefits of investing in pandemic preparedness New modelling research, published in The Lancet Global Health journal, estimates that it could cost low- and middle-income countries (LMICs) around US$52 billion (equivalent to US$8.60

Research 40

Research Development Medicine 40

pharmaphorum

JANUARY 24, 2022

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise. IBM’s step back from health comes as tech rivals are still piling into the sector.

Radiology 109

Radiology Marketing Genome Genomics 109

pharmaphorum

JULY 23, 2019

How can pharmaceutical marketers capitalise on this trend and free up budget to invest in additional marketing channels? The expert panel will consider exclusive research carried out by Tag and pharmaphorum across the US, Europe and Asia-Pacific among senior decision-makers in pharma and FMCG marketing.

Marketing 52

Marketing Production Development Research 52

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Rather than investing more in R&D, most pharma companies feel its more cost-effective to buy small biotech companies developing unique molecules that can find a market niche.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

XTalks

NOVEMBER 10, 2020

Implementing these technologies would require investing in handheld computers and tablets, barcode label printers and scanners, and special labels and tags. The increased globalization of food supply chains is likely to bring with it more obstacles and complications, but also growth opportunities.

Production 105

Production Sales Manufacturing Regulation 105

Rethinking Clinical Trials

JULY 14, 2023

Resources are a perennial challenge, pediatric well visits are full of competing priorities, and return of investment takes time to unfold. Tags #pctGR, @Collaboratory1 The post Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

The Pharma Data

JANUARY 31, 2021

The Coalition for Epidemic Preparedness Innovations (CEPI) has committed to fund Clover’s S-Trimer COVID-19 vaccine candidate through licensure with a total investment of up to $328 million , a portion of which will support the global Phase 2/3 study. About Trimer-Tag© Technology. —- End —-.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

Rethinking Clinical Trials

JULY 6, 2023

DCTs are not only more convenient for trial participants, but they often provide a positive return on investment for the trial itself. As IRBs and ethics committees review of DCTs, they can use newly developed recommendations for what should be submitted and discussions that should occur once the appropriate documents are submitted.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

XTalks

OCTOBER 28, 2021

The release of the cake mix comes just weeks after Perfect Day secured another $350 million from a Series D funding round led by the Canada Pension Plan Investment Board and Temasek Holdings. The latest investment brings the company’s total funding amount to $711.5 percent from 2019 to 2025.

Protein 98

Protein Packaging Packaging DNA 98

Rethinking Clinical Trials

SEPTEMBER 16, 2022

People had to very quickly decide where are our priorities, invest resources, do clinical trials, move into an environment with little patient/provider contact, and suddenly folks from multiple parts of the institution were together making decisions. -Has COVID-19 shifted the dynamic of Learning Health Systems, and if so, how? Learn more.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Research 100

XTalks

JULY 16, 2021

But yet, the price tag is still higher than real meat. A pound of Beyond Meat’s Beef burgers carries a price tag of $6.25, Vox reported. Therefore, instead of cutting R&D, companies should invest more into it and look to lower costs in other areas of the manufacturing process. Turning a Profit. Learning From the Experts.

Protein 105

Protein Production Manufacturing Branding 105

Rethinking Clinical Trials

AUGUST 18, 2022

Because the system and structures have not been built equitability, we will need to invest more and have more transparency and accountability at every level, from the investigator, funder, publisher and journals. Vanderbilt University Medical Center. Equity, Diversity, Recruitment. Key Points. It is everyone’s responsibility. New Ideas study.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Insulin 130

XTalks

FEBRUARY 8, 2024

Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla.

Life Science 105

Life Science Marketing Branding Drugs 105

XTalks

APRIL 18, 2024

Previously, Roche secured an FDA breakthrough tag for another one of its Alzheimer’s blood tests that detects levels of pTau-181 and ApoE4 (apolipoprotein e4). Last month, Eisai announced a $15 million investment to support the expansion of the tests with respect to availability, accessibility, affordability and utilization across the US.

Clinical Trials 52

Clinical Trials Clinical Trials In-Vitro Protein 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Regulation 78

Regulation Marketing Sales Branding 78

pharmaphorum

JANUARY 21, 2022

And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccines, quickly followed by inequities in access. There is no easy answer to the question of how to incentivise innovation without restricting access.

Medicine 52

Medicine Marketing Manufacturing Production 52

The Pharma Data

DECEMBER 3, 2020

Utilizing Clover’s proprietary Trimer-Tag © technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag © Technology. Trimer-Tag © is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

pharmaphorum

JANUARY 11, 2021

They will also be better at raising money with tailored investment theses and increased strategic flexibility. million price tag. Laying out the rationale for the spin-off, bluebird said that operating individually the two companies will be more effective at allocating capital.

Gene Therapy 59

Gene Therapy Gene Genetic Disease Manufacturing 59

The Pharma Data

JANUARY 31, 2021

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins.

Vaccination 52

Vaccination Vaccine Trials Protein 52

Delveinsight

FEBRUARY 9, 2021

The move came not long after healthcare investor giant Deerfield Management has forged a partnership to create the Center for Protein Degradation, investing worth USD 80 million. For the same reason, Deerfield has decided to invest USD 130 Million over the next ten years at Dana-Farber.

FDA Approval 52

FDA Approval Marketing Research Protein 52

pharmaphorum

JANUARY 31, 2023

Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. Finally, the belief that pharmaceutical companies prioritise their bottom lines over the health and well-being of patients is probably the largest contributing factor to lack of trust in the industry.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52